ArticleBMC gastroenterology2026
Effects of age and drug use on lower gastrointestinal bleeding: a retrospective single-center experience.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effects of BMI and Anticoagulant/Antiplatelet Therapy on the Severity of Gastrointestinal Bleeding.Medicina (Kaunas, Lithuania) · 2026Article
- Assessment of the Prognostic Performance of the Oakland Score in Lower Gastrointestinal Bleeding: A Retrospective Cohort Study.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsLower gastrointestinal bleeding is a prevalent issue in the general population, particularly among older adults. Identifying risk factors is essential for improving healthcare outcomes. This study seeks to evaluate the clinical outcomes related to the use of medications recognized as risk factors, as well as the influence of age, in patients experiencing lower gastrointestinal hemorrhage. The primary endpoint of the study is to examine the effect of age and medication use on 30-day mortality, while the secondary endpoint was to investigate the need for endoscopic treatment, amount of transfusion, need for surgery-embolization, and length of hospital stay.
methodsA retrospective cohort analysis was conducted on patients with lower gastrointestinal bleeding who were admitted to the emergency department at a single tertiary referral center. Patients were divided into two groups: those under 65 years of age and those aged 65 and older. Additionally, the older patients were further categorized into subgroups based on the specific antiplatelet or anticoagulant medications they were taking. We examined the demographic information of the patients, their presenting findings, colonoscopic diagnoses, the number of erythrocyte transfusions received, the need for embolization or surgery, the length of hospital stay, and the rates of 30-day mortality.
resultsA total of 181 patients were retrospectively reviewed. Of the patients, 113 (62.4%) were aged over 65 years, while 68 (37.6%) were aged under 65 years. The most common cause of bleeding in geriatric patients is colonic diverticula (39%), while in the other group it is hemorrhoids/anal fissures (35%). The 30-day mortality, need for transfusion, number of transfusions, and length of hospital stay were higher in the geriatric group. 105 patients (58%) were receiving anticoagulant, antiplatelet, or nonsteroidal anti-inflammatory drugs. In geriatric patients, medication history did not affect endoscopic treatment, 30-day mortality, surgical needs, the number and amount of transfusions, or length of hospital stay.
conclusionsLower gastrointestinal bleeding has more adverse outcomes in geriatric people. Although anticoagulant and antiplatelet medications increase the risk of bleeding, they have not significantly influenced the clinical outcomes associated with it.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.